{"id":"https://openalex.org/W4367053345","doi":"https://doi.org/10.3389/fimmu.2023.1156714","title":"Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer","display_name":"Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer","publication_year":2023,"publication_date":"2023-04-26","ids":{"openalex":"https://openalex.org/W4367053345","doi":"https://doi.org/10.3389/fimmu.2023.1156714","pmid":"https://pubmed.ncbi.nlm.nih.gov/37180141","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10169702"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2023.1156714","doi":"https://doi.org/10.3389/fimmu.2023.1156714","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2023.1156714","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2023.1156714/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2023.1156714/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035993804","display_name":"Anna Morena D\u2019Alise","orcid":"https://orcid.org/0000-0002-0763-6269","observed_orcids":["https://orcid.org/0000-0002-0763-6269"]},"institutions":[{"id":"https://openalex.org/I4210149296","display_name":"Nouscom (Italy)","ror":"https://ror.org/042dk0329","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210149296"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Anna Morena D\u2019Alise","raw_affiliation_strings":["Nouscom Srl, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nouscom Srl, Rome, Italy","institution_ids":["https://openalex.org/I4210149296"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052646548","display_name":"Linda Nocchi","orcid":"https://orcid.org/0000-0002-2113-9031","observed_orcids":["https://orcid.org/0000-0002-2113-9031"]},"institutions":[{"id":"https://openalex.org/I4210149296","display_name":"Nouscom (Italy)","ror":"https://ror.org/042dk0329","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210149296"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Linda Nocchi","raw_affiliation_strings":["Nouscom Srl, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nouscom Srl, Rome, Italy","institution_ids":["https://openalex.org/I4210149296"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063622946","display_name":"Irene Garzia","orcid":"https://orcid.org/0009-0008-3001-2674","observed_orcids":["https://orcid.org/0009-0008-3001-2674"]},"institutions":[{"id":"https://openalex.org/I4210149296","display_name":"Nouscom (Italy)","ror":"https://ror.org/042dk0329","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210149296"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Irene Garzia","raw_affiliation_strings":["Nouscom Srl, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nouscom Srl, Rome, Italy","institution_ids":["https://openalex.org/I4210149296"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075548163","display_name":"Laura Secl\u00ec","orcid":"https://orcid.org/0000-0001-7129-3355","observed_orcids":["https://orcid.org/0000-0001-7129-3355"]},"institutions":[{"id":"https://openalex.org/I4210149296","display_name":"Nouscom (Italy)","ror":"https://ror.org/042dk0329","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210149296"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Laura Secl\u00ec","raw_affiliation_strings":["Nouscom Srl, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nouscom Srl, Rome, Italy","institution_ids":["https://openalex.org/I4210149296"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034298142","display_name":"Luigia Infante","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I116067653","display_name":"University of Rome Tor Vergata","ror":"https://ror.org/02p77k626","country_code":"IT","type":"education","lineage":["https://openalex.org/I116067653"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Luigia Infante","raw_affiliation_strings":["Department of Biology, University of Rome \"Tor Vergata\", Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biology, University of Rome \"Tor Vergata\", Rome, Italy","institution_ids":["https://openalex.org/I116067653"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013594065","display_name":"Fulvia Troise","orcid":"https://orcid.org/0000-0002-4815-1495","observed_orcids":["https://orcid.org/0000-0002-4815-1495"]},"institutions":[{"id":"https://openalex.org/I4210149296","display_name":"Nouscom (Italy)","ror":"https://ror.org/042dk0329","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210149296"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Fulvia Troise","raw_affiliation_strings":["Nouscom Srl, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nouscom Srl, Rome, Italy","institution_ids":["https://openalex.org/I4210149296"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073524051","display_name":"Gabriella Cotugno","orcid":"https://orcid.org/0009-0009-5880-0215","observed_orcids":["https://orcid.org/0009-0009-5880-0215"]},"institutions":[{"id":"https://openalex.org/I4210149296","display_name":"Nouscom (Italy)","ror":"https://ror.org/042dk0329","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210149296"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gabriella Cotugno","raw_affiliation_strings":["Nouscom Srl, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nouscom Srl, Rome, Italy","institution_ids":["https://openalex.org/I4210149296"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048923591","display_name":"Simona Allocca","orcid":"https://orcid.org/0009-0009-4451-8497","observed_orcids":["https://orcid.org/0009-0009-4451-8497"]},"institutions":[{"id":"https://openalex.org/I4210149296","display_name":"Nouscom (Italy)","ror":"https://ror.org/042dk0329","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210149296"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Simona Allocca","raw_affiliation_strings":["Nouscom Srl, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nouscom Srl, Rome, Italy","institution_ids":["https://openalex.org/I4210149296"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Giuseppina Romano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210149296","display_name":"Nouscom (Italy)","ror":"https://ror.org/042dk0329","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210149296"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppina Romano","raw_affiliation_strings":["Nouscom Srl, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nouscom Srl, Rome, Italy","institution_ids":["https://openalex.org/I4210149296"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000269292","display_name":"Armin Lahm","orcid":"https://orcid.org/0000-0002-2859-4379","observed_orcids":["https://orcid.org/0000-0002-2859-4379"]},"institutions":[{"id":"https://openalex.org/I4210149296","display_name":"Nouscom (Italy)","ror":"https://ror.org/042dk0329","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210149296"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Armin Lahm","raw_affiliation_strings":["Nouscom Srl, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nouscom Srl, Rome, Italy","institution_ids":["https://openalex.org/I4210149296"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055345185","display_name":"Guido Leoni","orcid":"https://orcid.org/0000-0003-0502-1962","observed_orcids":["https://orcid.org/0000-0003-0502-1962"]},"institutions":[{"id":"https://openalex.org/I4210149296","display_name":"Nouscom (Italy)","ror":"https://ror.org/042dk0329","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210149296"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Guido Leoni","raw_affiliation_strings":["Nouscom Srl, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nouscom Srl, Rome, Italy","institution_ids":["https://openalex.org/I4210149296"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005207675","display_name":"Emanuele Sasso","orcid":"https://orcid.org/0000-0002-6454-2824","observed_orcids":["https://orcid.org/0000-0002-6454-2824"]},"institutions":[{"id":"https://openalex.org/I4210128854","display_name":"CEINGE Biotecnologie Avanzate Franco Salvatore (Italy)","ror":"https://ror.org/033pa2k60","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210128854"]},{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Emanuele Sasso","raw_affiliation_strings":["CEINGE-Advanced Biotechnologies s.c. a.r.l., Naples, Italy","Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CEINGE-Advanced Biotechnologies s.c. a.r.l., Naples, Italy","institution_ids":["https://openalex.org/I4210128854"]},{"raw_affiliation_string":"Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006663756","display_name":"Elisa Scarselli","orcid":"https://orcid.org/0000-0002-5393-6713","observed_orcids":["https://orcid.org/0000-0002-5393-6713"]},"institutions":[{"id":"https://openalex.org/I4210149296","display_name":"Nouscom (Italy)","ror":"https://ror.org/042dk0329","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210149296"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Elisa Scarselli","raw_affiliation_strings":["Nouscom Srl, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nouscom Srl, Rome, Italy","institution_ids":["https://openalex.org/I4210149296"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022640226","display_name":"Alfredo Nicosia","orcid":"https://orcid.org/0000-0002-4731-5822","observed_orcids":["https://orcid.org/0000-0002-4731-5822"]},"institutions":[{"id":"https://openalex.org/I4210128854","display_name":"CEINGE Biotecnologie Avanzate Franco Salvatore (Italy)","ror":"https://ror.org/033pa2k60","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210128854"]},{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alfredo Nicosia","raw_affiliation_strings":["CEINGE-Advanced Biotechnologies s.c. a.r.l., Naples, Italy","Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CEINGE-Advanced Biotechnologies s.c. a.r.l., Naples, Italy","institution_ids":["https://openalex.org/I4210128854"]},{"raw_affiliation_string":"Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5035993804"],"corresponding_institution_ids":["https://openalex.org/I4210149296"],"apc_list":{"value":3295,"currency":"USD","value_usd":3295},"apc_paid":{"value":3295,"currency":"USD","value_usd":3295},"fwci":1.407,"has_fulltext":true,"cited_by_count":14,"citation_normalized_percentile":{"value":0.79131912,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"14","issue":null,"first_page":"1156714","last_page":"1156714"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.8179000020027161,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.8179000020027161,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.16189999878406525,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.010400000028312206,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adenovirus-vectors","display_name":"adenoviral vector","score":0.6010000109672546},{"id":"https://openalex.org/keywords/anti-ctla-4-monoclonal-antibody","display_name":"anti-CTLA-4 monoclonal antibody","score":0.9559999704360962},{"id":"https://openalex.org/keywords/ctla-4","display_name":"CTLA-4","score":0.7170000076293945},{"id":"https://openalex.org/keywords/covid-19-vaccines","display_name":"COVID-19 vaccines","score":0.9110000133514404},{"id":"https://openalex.org/keywords/spike-protein","display_name":"spike protein","score":0.6949999928474426},{"id":"https://openalex.org/keywords/neoantigens","display_name":"neoantigens","score":0.8349999785423279},{"id":"https://openalex.org/keywords/multiepitope-vaccine","display_name":"multi-epitope vaccine","score":0.9350000023841858},{"id":"https://openalex.org/keywords/humoral-and-cellular-immune-response","display_name":"humoral and cellular immune response","score":0.7329999804496765},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.6380000114440918}],"concepts":[{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.9029912948608398},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6895533204078674},{"id":"https://openalex.org/C32470452","wikidata":"https://www.wikidata.org/wiki/Q2298489","display_name":"Viral vector","level":4,"score":0.6701545715332031},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.6520780920982361},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5082890391349792},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.47085946798324585},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4680124521255493},{"id":"https://openalex.org/C2776954459","wikidata":"https://www.wikidata.org/wiki/Q193447","display_name":"Adenoviridae","level":4,"score":0.45549046993255615},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.429738312959671},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4213974177837372},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3252212107181549},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.20321431756019592},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.10778611898422241},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.08681750297546387},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000086663","descriptor_name":"COVID-19 Vaccines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000256","descriptor_name":"Adenoviridae","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000257","descriptor_name":"Adenoviridae Infections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000277","descriptor_name":"Adjuvants, Pharmaceutic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003141","descriptor_name":"Communicable Diseases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D062705","descriptor_name":"Adenovirus Vaccines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.3389/fimmu.2023.1156714","doi":"https://doi.org/10.3389/fimmu.2023.1156714","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2023.1156714","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2023.1156714/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10169702","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10169702","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10169702/pdf/fimmu-14-1156714.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:37180141","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37180141","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:c5b5ae6ddbf446d391d69e7a9c8a7e47","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/c5b5ae6ddbf446d391d69e7a9c8a7e47","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 14 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2023.1156714","doi":"https://doi.org/10.3389/fimmu.2023.1156714","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2023.1156714","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2023.1156714/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322218","display_name":"Regione Campania","ror":"https://ror.org/02kg21794"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4367053345.pdf","grobid_xml":"https://content.openalex.org/works/W4367053345.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W1967889234","https://openalex.org/W2006759360","https://openalex.org/W2014876227","https://openalex.org/W2053248202","https://openalex.org/W2101581360","https://openalex.org/W2106074988","https://openalex.org/W2107712147","https://openalex.org/W2109737479","https://openalex.org/W2121049053","https://openalex.org/W2123761806","https://openalex.org/W2149140113","https://openalex.org/W2523360403","https://openalex.org/W2753885123","https://openalex.org/W2782708334","https://openalex.org/W2795781326","https://openalex.org/W2887577080","https://openalex.org/W2895762589","https://openalex.org/W2926361578","https://openalex.org/W2943197912","https://openalex.org/W2946771227","https://openalex.org/W2950380724","https://openalex.org/W3007791850","https://openalex.org/W3154522465","https://openalex.org/W3216918365","https://openalex.org/W4210348552","https://openalex.org/W4285729344","https://openalex.org/W4291020795","https://openalex.org/W4291790128","https://openalex.org/W4293206087"],"related_works":["https://openalex.org/W4416446649","https://openalex.org/W2487671468","https://openalex.org/W2554901784","https://openalex.org/W4226069962","https://openalex.org/W4409376913","https://openalex.org/W2168453650","https://openalex.org/W2620739989","https://openalex.org/W2338153609","https://openalex.org/W1984244952","https://openalex.org/W1968124827"],"abstract_inverted_index":{"Introduction:":[0],"Virus":[1],"vectored":[2],"genetic":[3,35,54,68,106,237],"vaccines":[4,24,69],"(Vvgv)":[5],"represent":[6],"a":[7,60,98,105,137,230],"promising":[8],"approach":[9,63,232],"for":[10,67,108],"eliciting":[11],"immune":[12,132,191,222],"protection":[13],"against":[14],"infectious":[15],"diseases":[16],"and":[17,76,130,193,226],"cancer.":[18],"However,":[19],"at":[20,162],"variance":[21],"with":[22,32,83,117,147,216],"classical":[23],"to":[25,39,64,72,224,233],"date,":[26],"no":[27],"adjuvant":[28,82,107,139,160,177],"has":[29],"been":[30],"combined":[31],"clinically":[33],"approved":[34],"vaccines,":[36],"possibly":[37],"due":[38],"the":[40,44,49,53,78,81,86,123,145,148,156,159,166,170,176,184,190,209],"detrimental":[41],"effect":[42,140],"of":[43,80,85,115,158,165,179,195,211],"adjuvant-induced":[45],"innate":[46],"response":[47,192],"on":[48],"expression":[50],"driven":[51],"by":[52],"vaccine":[55,121,146,167,185,200,220],"vector.":[56],"We":[57,173],"reasoned":[58],"that":[59,84,175,208],"potential":[61],"novel":[62],"develop":[65,234],"adjuvants":[66],"would":[70],"be":[71],"\"synchronize\"":[73],"in":[74,127,151],"time":[75],"space":[77],"activity":[79,178],"vaccine.":[87],"Methods:":[88],"To":[89],"this":[90],"aim,":[91],"we":[92],"generated":[93],"an":[94,118,196,217],"Adenovirus":[95,109,197,212],"vector":[96,161,168],"encoding":[97,122,201],"murine":[99],"anti-CTLA-4":[100,150],"monoclonal":[101],"antibody":[102],"(Ad-9D9)":[103],"as":[104,187],"based":[110,198],"vaccines.":[111,238],"Results:":[112],"The":[113],"co-delivery":[114],"Ad-9D9":[116],"Adeno-based":[119],"COVID-19":[120],"Spike":[124],"protein":[125],"resulted":[126],"stronger":[128],"cellular":[129],"humoral":[131],"responses.":[133],"In":[134],"contrast,":[135],"only":[136],"modest":[138],"was":[141],"achieved":[142],"when":[143],"combining":[144],"same":[149],"its":[152],"proteinaceous":[153],"form.":[154],"Importantly,":[155],"administration":[157],"different":[163],"sites":[164],"abrogates":[169],"immunostimulatory":[171],"effect.":[172],"showed":[174],"Ad-\u03b1-CTLA-4":[180],"is":[181],"independent":[182],"from":[183],"antigen":[186,219],"it":[188],"improved":[189],"efficacy":[194],"polyepitope":[199],"tumor":[202,227],"neoantigens.":[203],"Discussion:":[204],"Our":[205],"study":[206],"demonstrated":[207],"combination":[210],"Encoded":[213],"Adjuvant":[214],"(AdEnA)":[215],"Adeno-encoded":[218],"enhances":[221],"responses":[223],"viral":[225],"antigens,":[228],"representing":[229],"potent":[231],"more":[235],"effective":[236]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-04-27T00:00:00"}